Form 4: OPKO Health Director Krasno Acquires 30,000 Stock Options
SEC Form 4 Filing
Director Richard M. Krasno acquired 30,000 stock options in OPKO Health, Inc. on April 23, 2025.
Summary
- Richard M. Krasno, a director of OPKO Health, Inc., reported a transaction on April 23, 2025.
- Krasno acquired 30,000 stock options with an exercise price of $1.47.
- The options are exercisable from April 23, 2026, and expire on April 22, 2035.
- Following the transaction, Krasno directly owns 30,000 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock option acquisition by a director, which can be interpreted as a sign of confidence, but it's not overwhelmingly positive or negative.
Positives
- A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.
Stakeholder Impact
- The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 04/23/2025 | Date of transaction: acquisition of stock options. |
| 04/23/2026 | Date the stock options become exercisable. |
| 04/22/2035 | Expiration date of the stock options. |
Keywords
OPKO Health, Director, Stock Options, Acquisition, Form 4, Krasno, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.